[In vitro study of leishmanicidal agents with drug carriers].
Antileishmanial chemotherapy is hampered by the location of parasites within lysosomal vacuoles of the macrophages which restricts the bioavailability of many potential antileishmanial compounds. In this study, the effectiveness of pentamidine targeted to the infected cells by a linkage to a colloidal drug carrier, methacrylate polymer nanoparticles was explored. In the same way, polyisoalkylcyanoacrylate nanospheres which have, in vitro, trypanolytic properties were also tested. The study was performed in an in vitro model using Leishmania major amastigote stages within the U 937 human monohistiocytic cell line. The antileishmanial activities of unloaded or pentamidine-loaded nanoparticles were compared to those of the free drugs. The 50% effective concentration of targeted pentamidine was 0.10 microgram/ml, while it was up to 2.7 micrograms/ml with the free drug after a 24-hour incubation time. The pentamidine-bound nanoparticles proved to be 25 times more active than the free drug. Unloaded polyisoalkylcyanoacrylate nanoparticles destroyed intracellular amastigote stages (50% EC = 15 micrograms/ml) but at a level close to the cytotoxic concentration.
Laboratoire de Parasitologie, Faculté de Médecine, Paris XII, Créteil.
M
M
Deniau
R
R
Durand
C
C
Bories
M
M
Paul
A
A
Astier
P
P
Couvreur
R
R
Houin
D002460:Cell Line; D003487:Cyanoacrylates / Q000008:administration & dosage*; D004337:Drug Carriers; D004341:Drug Evaluation; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy*; D010419:Pentamidine / Q000008:administration & dosage* / Q000627:therapeutic use; D011109:Polymethacrylic Acids / Q000008:administration & dosage*
D003487:Cyanoacrylates; D004337:Drug Carriers; D011109:Polymethacrylic Acids; D010419:Pentamidine
Etude in vitro de médicaments leishmanicides vectorisés.